Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Ardelyx Inc (NQ: ARDX )

7.360 USD -0.330 (-4.29%)
Official Closing Price Updated: 6:14 PM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 589,300
Open 7.650
Bid (Size) 7.000 (10)
Ask (Size) 7.570 (3)
Prev. Close 7.690
Today's Range 7.280 - 7.860
52wk Range 4.220 - 8.815
Shares Outstanding 60,103,568
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Ardelyx to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiovascular diseases, today... 
From PR Newswire
Ardelyx to Present at the Jefferies Virtual London Healthcare Conference
Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiovascular diseases, today... 
From PR Newswire

Performance

YTD
+13.76%
+13.76%
1 Month
+8.00%
+8.00%
3 Month
+39.39%
+39.39%
6 Month
+20.07%
+20.07%
1 Year
+0.55%
+0.55%

More News

Read More
Ardelyx to Webcast Virtual Analyst Day
From PR Newswire
Ardelyx Reports Third Quarter 2020 Financial Results and Business Highlights
From PR Newswire
12 Health Care Stocks Moving In Friday's After-Market Session
Tags ALRN BNGO DFFN
From Benzinga
Ardelyx and Kyowa Kirin Highlight New Data Supporting the Clinical Safety and Efficacy of First-In-Class, Phosphate Absorption Inhibitor Tenapanor at ASN's Kidney Week 2020
From PR Newswire
Ardelyx Launches 'Can We Do Better?' Campaign at ASN's Kidney Week 2020
From PR Newswire
Thinking about buying stock in Capricor Therapeutics, Cardtronics, Clearside Biomedical, Ardelyx, or FuelCell Energy?
From PR Newswire
Analysts Expect LABU To Hit $150
Tags ETFs
From ETF Channel
Top Buys by Directors: Mott's $1M Bet on ARDX
Tags Stocks
From Market News Video
Noteworthy Thursday Option Activity: ARDX, IIPR, MGNX
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.